| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
-Aminocaproic Acid or Placebo in Liver Transplantation
Departments of
*Anaesthesiology and
Surgery, Princeps D’Espanya Hospital, Barcelona; and Departments of
Anaesthesiology and
§Surgery, Virgen Arrixaca Hospital, Murcia, Spain
Address correspondence and reprint requests to Antonia Dalmau, MD, C/Auladell No. 4, 1°–2°, Sant Cugat, Barcelona 08190, Spain. Address e-mail to antonia{at}servinter.com
We evaluated the efficacy of the prophylactic administration of 
-aminocaproic acid and tranexamic acid for reducing blood product requirements in orthotopic liver transplantation (OLT) in a prospective, double-blinded study performed in 132 consecutive patients. Patients were randomized to three groups and given one of three drugs prophylactically: tranexamic acid, 10 mg · kg-1 · h-1; -aminocaproic acid, 16 mg · kg-1 · h-1, and placebo (isotonic saline). Perioperative management was standardized. Coagulation tests, thromboelastogram, and blood requirements were recorded during OLT and in the first 24 h. There were no differences in diagnosis, Child score, or preoperative coagulation tests among groups. Administration of packed red blood cells was significantly reduced (P = 0.023) during OLT in the tranexamic acid group, but not in the -aminocaproic acid group. There were no differences in transfusion requirements after OLT. Thromboembolic events, reoperations, and mortality were similar in the three groups. Prophylactic administration of tranexamic acid, but not -aminocaproic acid, significantly reduces total packed red blood cell usage during OLT.
Implications: In a randomized study of 132 consecutive patients undergoing liver transplantation, we found that tranexamic acid, but not -aminocaproic acid, reduced intraoperative total packed red blood cell transfusion.
This article has been cited by other articles:
|
|
 |
|
  M. T. de Boer, M. C. Christensen, M. Asmussen, C. S. van der Hilst, H. G. D. Hendriks, M. J. H. Slooff, and R. J. Porte The Impact of Intraoperative Transfusion of Platelets and Red Blood Cells on Survival After Liver Transplantation Anesth. Analg., January 1, 2008; 106(1): 32 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ozier and S. Schlumberger Pharmacological approaches to reducing blood loss and transfusions in the surgical patient: [Approches pharmacologiques de reduction des pertes sanguines et des transfusions en chirurgie] Can J Anesth, June 1, 2006; 53(6_suppl): S21 - S29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Camarasa, G. Olle, M. Serra-Prat, A. Martin, M. Sanchez, P. Ricos, A. Perez, and L. Opisso Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial Br. J. Anaesth., May 1, 2006; 96(5): 576 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jackson, A. Botea, Y. Gubenko, E. Delphin, and H. Bennett Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis. Anesth. Analg., March 1, 2006; 102(3): 724 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Lerner, E. Sundar, F. Mahmood, T. Sarge, D. W. Hanto, and P. J. Panzica Four Cases of Cardiopulmonary Thromboembolism During Liver Transplantation Without the Use of Antifibrinolytic Drugs Anesth. Analg., December 1, 2005; 101(6): 1608 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lentschener, K. Roche, and Y. Ozier A Review of Aprotinin in Orthotopic Liver Transplantation: Can Its Harmful Effects Offset Its Beneficial Effects? Anesth. Analg., May 1, 2005; 100(5): 1248 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamasaki, K. Masuhara, and T. Fuji Tranexamic Acid Reduces Postoperative Blood Loss in Cementless Total Hip Arthroplasty J. Bone Joint Surg. Am., April 1, 2005; 87(4): 766 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Mahdy and N. R. Webster Perioperative systemic haemostatic agents Br. J. Anaesth., December 1, 2004; 93(6): 842 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Massicotte, M.-P. Sassine, S. Lenis, and A. Roy Transfusion Predictors in Liver Transplant Anesth. Analg., May 1, 2004; 98(5): 1245 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Steib, G. Freys, C. Lehmann, C. Meyer, and G. Mahoudeau Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict : [Les pertes sanguines peroperatoires et les besoins transfusionnels restent toujours difficiles a predire pendant la greffe du foie] Can J Anesth, December 1, 2001; 48(11): 1075 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dalmau, A. Sabate, M. Koo, A. Rafecas, J. Figueras, and E. Jaurrieta Prophylactic use of Tranexamic Acid and Incidence of Arterial Thrombosis in Liver Transplantation Anesth. Analg., August 1, 2001; 93(2): 516 - 516. [Full Text] [PDF]
|
|
|
|
|
|
B. M. Parker, S. A. Irefin, C. J. O'Connor, and K. J. Tuman Antifibrinolytic Therapy and Pulmonary Thromboembolism During Orthotopic Liver Transplantation Anesth. Analg., February 1, 2001; 92(2): 559 - 560. [Full Text] [PDF]
|
|
|
